{"database": "lobbying", "table": "lobbying_activities", "rows": [[2023598, "449c2366-3667-4575-bd85-ee7e0bc6c1eb", "Q3", "THE CHARLES GROUP, LLC", 53458, "NEWPORT BRAIN RESEARCH LABORATORY, INC.", 2017, "third_quarter", "VET", "Discussing effective treatments for veterans suffering from PTSD, TBI, chronic pain, and other related effects such as substance abuse issues.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2017-10-13T13:48:27.810000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2023598"], "units": {}, "query_ms": 16.83609001338482, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}